Xu Lina, Wang Pengli, Wang Yufeng, Liu Bingjie, Xu Xuena, Yang Quying, Gao Chunyan, Sun Huiquan, Xu Yuejuan, Xu Qiuyan, Hao Chuangli, Jiang Wujun
Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.
Department of Respiratory Medicine, Children's Hospital of Wujiang District, Suzhou, China.
Front Microbiol. 2024 Oct 15;15:1483152. doi: 10.3389/fmicb.2024.1483152. eCollection 2024.
This study examines the epidemiology of () infections among children in Suzhou, China, during various pandemic phases. The goal is to discern evolving epidemic trends and to furnish robust evidence for clinical diagnosis and treatment.
From January 1, 2016, to December 31, 2023, 113,625 consecutive patients with respiratory infections from three hospitals in Suzhou, China (Children's Hospital of Soochow University, Children's Hospital of Wujiang District, and Affiliated Suzhou Hospital of Nanjing University Medical School), were retrospectively enrolled in a surveillance study. Additionally, in 2023, children hospitalized with pneumonia at the Children's Hospital of Soochow University were tested for genotype (P1 gene typing, SNP genotyping) and macrolide resistance in their bronchoalveolar lavage fluid.
From 2016 to 2023, the positive detection rate among pediatric respiratory infections fell from a pre-pandemic 21.1% to pandemic lows, then surged to 45.3% post-pandemic. Before the pandemic, peak infection rates occurred in summer, followed by autumn. Post-pandemic, the highest peak rates were in autumn. Peak detection rates occurred in 2019 and 2023, with a notable increase in children aged 6 and older in 2023. In this study, 200 -positive bronchoalveolar lavage fluid (BALF) cases in 2023 were randomly selected and analyzed for P1 genotype and SNP genotype. Among 156 cases, 81.4% were P1 genotype and 18.6% were P2 genotype. The proportion of severe pneumonia with the P1 type was significantly higher than that with the P2 type ( < 0.05). Of the 192 samples analyzed, 11 SNP genotypes were identified, with SNP-27 predominating (36.5%), followed by SNP-0 (21.4%), SNP-11 (18.8%), and SNP-34 (17.7%). Of the 192 BALF specimens, 97.3% exhibited macrolide resistance mutations, with A2063G mutations at 96.17%. The mutation rates for the 23S rRNA 2064 and 2,617 were 1.6 and 1.0%, respectively.
Post-COVID-19 in Suzhou, China, infection patterns shifted significantly, with initial NPIs-induced declines followed by a sharp rise in cases, especially impacting school-age children. This trend underscores the importance of ongoing epidemiological surveillance and the development of strategic public health responses.
本研究调查了中国苏州儿童在不同疫情阶段的()感染流行病学情况。目的是识别不断演变的流行趋势,并为临床诊断和治疗提供有力证据。
2016年1月1日至2023年12月31日,对中国苏州三家医院(苏州大学附属儿童医院、吴江区儿童医院和南京大学医学院附属苏州医院)连续收治的113625例呼吸道感染患者进行回顾性监测研究。此外,2023年,苏州大学附属儿童医院收治的肺炎患儿的支气管肺泡灌洗液进行了基因型(P1基因分型、单核苷酸多态性基因分型)和大环内酯类耐药性检测。
2016年至2023年,儿童呼吸道感染中的()阳性检出率从疫情前的21.1%降至疫情期间的低点,然后在疫情后飙升至45.3%。疫情前,()感染率高峰出现在夏季,其次是秋季。疫情后,最高峰值出现在秋季。峰值检出率出现在2019年和2023年,2023年6岁及以上儿童显著增加。本研究随机选取2023年200例()阳性支气管肺泡灌洗液(BALF)病例进行P1基因型和单核苷酸多态性基因型分析。156例中,81.4%为P1基因型,18.6%为P2基因型。P1型重症()肺炎的比例显著高于P2型(<0.05)。在分析的192个样本中,鉴定出11种单核苷酸多态性基因型,其中SNP-27占主导(36.5%),其次是SNP-0(21.4%)、SNP-11(18.8%)和SNP-34(17.7%)。在192份BALF标本中,97.3%表现出大环内酯类耐药突变,其中A2063G突变占96.17%。23S rRNA 2064和2617的突变率分别为1.6%和1.0%。
在中国苏州,新冠疫情后,()感染模式发生了显著变化,最初因采取非药物干预措施导致病例数下降,随后病例数急剧上升,尤其对学龄儿童产生影响。这一趋势凸显了持续进行流行病学监测以及制定战略性公共卫生应对措施的重要性。